These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1622629)

  • 41. Molecular genetics of familial breast-ovarian cancer.
    van Rensburg EJ; Ponder BA
    J Clin Pathol; 1995 Sep; 48(9):789-95. PubMed ID: 7490308
    [No Abstract]   [Full Text] [Related]  

  • 42. Linkage analysis of 26 Canadian breast and breast-ovarian cancer families.
    Tonin P; Moslehi R; Green R; Rosen B; Cole D; Boyd N; Cutler C; Margolese R; Carter R; McGillivray B
    Hum Genet; 1995 May; 95(5):545-50. PubMed ID: 7759076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. No evidence for constitutional ATM mutation in breast/gastric cancer families.
    Bay JO; Grancho M; Pernin D; Presneau N; Rio P; Tchirkov A; Uhrhammer N; Verrelle P; Gatti RA; Bignon YJ
    Int J Oncol; 1998 Jun; 12(6):1385-90. PubMed ID: 9592204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Models of genetic susceptibility to breast cancer.
    Antoniou AC; Easton DF
    Oncogene; 2006 Sep; 25(43):5898-905. PubMed ID: 16998504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Linkage analysis of BRCA1 in Japanese breast cancer families.
    Inoue R; Fukutomi T; Ushijima T; Matsumoto Y; Sugimura T; Nagao M
    Jpn J Cancer Res; 1994 Dec; 85(12):1233-9. PubMed ID: 7852187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
    JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic evaluation based on family history and Her2 status correctly identifies TP53 mutations in very early onset breast cancer cases.
    Fostira F; Konstantopoulou I; Mavroudis D; Tryfonopoulos D; Yannoukakos D; Voutsinas GE
    Clin Genet; 2015 Apr; 87(4):383-7. PubMed ID: 24702488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
    Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
    J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
    Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The search for the familial breast/ovarian cancer gene.
    Black DM; Solomon E
    Trends Genet; 1993 Jan; 9(1):22-6. PubMed ID: 8434413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Familial versus sporadic breast cancer.
    Anderson DE
    Cancer; 1992 Sep; 70(6 Suppl):1740-6. PubMed ID: 1516029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast cancer susceptibility genes. BRCA1 and BRCA2.
    Brody LC; Biesecker BB
    Medicine (Baltimore); 1998 May; 77(3):208-26. PubMed ID: 9653432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA.
    Simard J; Feunteun J; Lenoir G; Tonin P; Normand T; Luu The V; Vivier A; Lasko D; Morgan K; Rouleau GA
    Hum Mol Genet; 1993 Aug; 2(8):1193-9. PubMed ID: 8401501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular responses to radiation and risk of breast cancer.
    Jongmans W; Hall J
    Eur J Cancer; 1999 Apr; 35(4):540-8. PubMed ID: 10492625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High incidence of cancer in a family segregating a mutation of the ATM gene: possible role of ATM heterozygosity in cancer.
    Bay JO; Uhrhammer N; Pernin D; Presneau N; Tchirkov A; Vuillaume M; Laplace V; Grancho M; Verrelle P; Hall J; Bignon YJ
    Hum Mutat; 1999; 14(6):485-92. PubMed ID: 10571946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology of susceptibility to breast cancer.
    Hulka BS
    Prog Clin Biol Res; 1996; 395():159-74. PubMed ID: 8895988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absence of p53 germ-line mutations in bilateral breast cancer patients.
    Lidereau R; Soussi T
    Hum Genet; 1992 May; 89(2):250-2. PubMed ID: 1587536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer risks from germ line tumor suppressor gene mutations.
    Frebourg T; Malkin D; Friend S
    Princess Takamatsu Symp; 1991; 22():61-70. PubMed ID: 1844252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.